ArticleProceedings of the National Academy of Sciences of the United States of America2008

In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Jagadeesh Bayry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.